SANDRA MURPHY: Open Payments
NPI 1922589795 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$798 in 32 payments from 9 companies in 2025. Trend: 2023 $1,081 · 2024 $788 · 2025 $798
Food & beverage: $798
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 12 | $252 |
| AstraZeneca Pharmaceuticals LP | 2 | $223 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $160 |
| GlaxoSmithKline, LLC. | 2 | $41 |
| Sumitomo Pharma America, Inc. | 2 | $40 |
| ABBVIE INC. | 1 | $29 |
| PFIZER INC. | 1 | $21 |
| Xeris Pharmaceuticals, Inc. | 1 | $17 |
| Amgen Inc. | 1 | $14 |
Products named: CAPLYTA, AIRSUPRA, Rybelsus, FARXIGA, Ozempic, Wegovy, SHINGRIX, GEMTESA.
Industry payments across TN — which companies pay providers there.
